• Follow us

Health

A Repurposed Drug Could Offer Hope after Many Alzheimer's Trial Failures

Neurodegenerative diseases all involve the accumulation of toxic versions of naturally produced proteins in the brain. Multiple proteins are often abnormal in a patient, and the same aberrant protein can be involved in several different conditions. One common culprit is tau, which is abnormal in various conditions: chronic traumatic encephalopathy, a neurodegenerative disorder caused by repeated head trauma; a group of conditions known collectively as frontotemporal dementia; and, most famously, Alzheimer’s disease (AD).

Normally, tau stabilizes structures inside neural connections, called microtubules, which facilitate chemical communication between cells. In disease states, tau is chemically altered, becoming misshapen and breaking away from microtubules. These toxic versions accumulate into structures called “neurofibrillary tangles,” which disrupt cells’ ability to communicate and may trigger other forms of damage, such as inflammation. Tau is involved in AD, but abnormalities in a different protein, amyloid-beta, are thought to be the initial trigger for a chain of biological events (including tau pathology) that underlies neurodegeneration. This is why most AD drugs developed to date have targeted amyloid, although tau has received increasing attention as multiple drugs intended to remove amyloid have failed.

A new study, published Wednesday in Science Translational Medicine, suggests that an existing drug, lonafarnib, could be repurposed to treat neurodegenerative diseases that involve tau. A team of researchers, led by neuroscientist Kenneth Kosik of the University of California, Santa Barbara, found the drug had beneficial effects on tau-related pathology in mice, if administered early over an extended period. They also found evidence suggesting it works via a previously unknown biological mechanism. “This opens up a previously completely unsuspected pathway for tau degradation,” says Kosik, a longtime tau researcher. “We don’t have all the molecular details, but as a place to look, this is full of new opportunities.”

The last big hope of a major advance for Alzheimer’s being just around the corner effectively died last week, when pharma company Biogen announced it was halting two late-stage clinical trials of an Alzheimer’s treatment, aducanumab. The drug was an antibody aimed at clearing the amyloid “plaques” that are found in the brains of people with Alzheimer’s disease. It had shown promise in early trial results, but, like many before, has fallen at the last hurdle. “Given the setback we've had recently, and many before that, with amyloid, the field is a little bit desperate to find new approaches,” Kosik says. “I think interest in tau is going to go up.”

The team first found that lonafarnib lowered abnormal tau in cell cultures, then turned to testing it in mice engineered to possess a mutant version of the human tau gene. These mice, which are commonly used as a model of frontotemporal dementia, start developing tau pathology, brain inflammation and behavioral problems, at around 10 weeks old, and by 20 weeks these problems all reach advanced stages. The researchers began giving the mice lonafarnib at 10 weeks, on an intermittent, five-day-on, five-day-off schedule, then evaluated them at 20 weeks. The treatment markedly reduced abnormal behaviors seen in untreated mice, such as continuously running in circles and a lack of normal nest-building behaviour. “It had rather dramatic effects,” Kosik says. “All the control animals, by 20 weeks, were just really sick, and our [treated mice] were not.” It also reduced tau abnormalities, tangle formation, brain atrophy and inflammation. “We were quite amazed to see there was very minimal deposition of tau tangles,” Kosik says. “And there was reduction, but not elimination, of brain inflammation known as microgliosis”.

The drug appears to work in a fundamentally different way to previous approaches, by activating cellular waste-clearance systems to break down the toxic proteins. Previous strategies have included reducing tau’s production, blocking its aggregation or switching off tau gene expression. These efforts have met with mixed success, but the new findings imply that the cells’ own systems can be recruited to clear pathological forms of tau. “The approach makes a lot of sense,” says neuroscientist Eckhard Mandelkow of the German Center for Neurodegenerative Diseases, who was not involved in the study.

These cleaning-out processes, collectively known as autophagy, deliver cellular debris to a compartment in the cell called the lysosome, which breaks down trash into its component parts for recycling. The team showed that all three known autophagy “routes” were affected by lonafranib, suggesting that the drug may exert its beneficial effects by influencing lysosome activity. Exactly how it does this is not clear, but it seems to involve a protein called Rhes.

Lonafranib blocks an enzyme (called farnesyltransferase) that normally facilitates the activity of a class of proteins, including Rhes, involved in the progression of the cycle of events that lead to cell division. That is why inhibitors of this enzyme—like lonafranib—have been tested as anti-cancer drugs. Why blocking Rhes from interacting with cells should enhance lysosome activity has not been pinned down, but Kosik’s team next wants to probe that question.

The researchers have other reasons to think lonafranib works by influencing Rhes, beyond just noting that it is one of the main targets of the enzyme that the drug blocks. First, when they analyzed which genes were disrupted in stem cell lines derived from people with tau mutations, the RASD2 gene that encodes Rhes turned up. Second, the researchers genetically manipulated Rhes levels in the mice’s brains directly. They found that reducing Rhes reproduced the effects they obtained with lonafranib treatment. This observation suggests the drug lowers Rhes levels, which in turn somehow activates lysosomal activity, which then clears the offending tau molecules. “It’s an intriguing therapeutic hypothesis,” says Larry Refolo, director of Alzheimer ’s disease drug discovery and development at the National Institute on Aging, a department of the National Institutes of Health, who was not involved in the study.

Lonafarnib has been extensively studied in cancer research and was labeled a breakthrough therapy for hepatitis-D by the FDA.* The drug already has a significant safety [profile] in different patient populations, making it attractive for repurposing for the treatment of tauopathies,” Refolo says. An important caveat is that the drug only had these effects when administered early. No benefit was seen in mice whose treatment began at 20 weeks. “It delays the onset, but does not reverse the pathology,” Mandelkow says. “However, this would be a major step, since a significant delay would enable patients to extend their meaningful life, a goal that has long been on the agenda of NIH.”

An intriguing possibility relates to the fact that the team found lowered, not raised, levels of Rhes in the human stem cell lines with mutant tau. “The reason we think it went down is these cells were detecting aberrant tau and self-regulating to lower Rhes levels as a means to activate autophagy and remove the aberrant proteins,” Kosik says. “Rhes seems to be modulating tau levels until its ability to do so is overcome.” The implication is that cells can sense even very low levels of abnormal tau. “If we’re right,” he adds, “the lysosomal system may even be detecting single molecules of aberrant tau and turning on a system to wipe them out.” If that thesis is correct, understanding how this process works might be lead to a new means for early  detection and treatment of Alzheimer’s.

Kosik argues that the detailed cell biology implicated by this research should be fully explored before ploughing on with clinical trials targeting tau. The leading approach at the moment is targeting tau with antibodies. “I really hope the tau people don’t make the same mistake the amyloid people have, by using a lot of tau antibody trials before we truly understand whether they’re engaging the correct target,” Kosik says. “We didn’t know that for amyloid, and we don’t know that for tau.”

Tau can take several forms, and geneticist Michel Goedert’s group at Cambridge University in the U.K., recently published evidence that different forms are specific to different conditions. Tau also exists in soluble (liquid) and insoluble forms (solid precipitates). “We don’t even know what the toxic form is yet,” Kosik says. Furthermore, researchers don’t yet know if antibodies can actually access the offending molecules, even if the right ones are identified. “There’s many reasons why we don’t have enough knowledge to invest hundreds of millions of dollars into tau antibody trials,” Kosik says. “And go through the same demoralization we have with amyloid.”

*Editor’s Note (3/28): This story was edited after posting. It incorrectly stated that lonafarnib had been approved for hepatitis-D but was not in use.

Read More



Leave A Comment

More News

Scientific American: Health

A Drug Shows an Astonishing Ability to Regenerate 2019-04-01 09:30:00A once abandoned drug compound shows an ability to rebuild organs damaged by illness and injury -- Read more on ScientificAmerican.com

Meta-Post: Posts on War and Peace 2019-03-31 15:00:00Cross-Check columns on war and related topics. -- Read more on ScientificAmerican.com

The Secrets of an Aging Athlete 2019-03-30 10:00:00Bestselling author and fitness guru Brad Kearns joins Get-Fit Guy, Brock Armstrong, to explain how we can stay fit now, and well into the future -- Re

The Case of a Woman Who Feels Almost 2019-03-30 08:00:00The discovery may have implications for treating acute and chronic pain -- Read more on ScientificAmerican.com

World's First HIV-to-HIV Kidney Transplant with Living Donor 2019-03-29 12:30:00The ability to use organs from living HIV-positive individuals could increase the supply available for transplant -- Read more on ScientificAmerican.c

A New Way to Fight Cancer 2019-03-29 12:00:00Metabolic therapy is showing promise in robbing malignant cells of their primary energy source -- Read more on ScientificAmerican.com

Repurposed Drug Could Offer Hope after Many Alzheimer's 2019-03-28 10:30:00An experimental drug for hepatitis D triggers a cellular waste disposal system to rid mice brains of the tau protein, a major culprit in neurodegenera

The <em>Other</em> Reasons People Don't Get Vaccines 2019-03-27 12:00:00When it comes to the flu, refusal often has nothing to do with the fear of autism -- Read more on ScientificAmerican.com

3 Myths (and 1 Truth) About Grain-Fed Beef 2019-03-27 11:15:00There’s a lot to consider when deciding what kind of meat to buy—or even whether to eat meat at all. The least we can do is start with acc

New Strategies Take On the Worst Cancer--Glioblastoma 2019-03-27 08:00:00Among the various malignancies that can afflict the human body, few bring with them the dour prognoses of brain tumors -- Read more on ScientificAmeri

Biogen Halts Studies of Closely Watched Alzheimer's Drug, 2019-03-22 10:00:00Trial failure raises doubts about amyloid as a target for drug development -- Read more on ScientificAmerican.com

Opting Out of Vaccines Should Opt You Out 2019-03-21 07:00:00People who are able to take vaccines but refuse to do so are the moral equivalent of drunk drivers -- Read more on ScientificAmerican.com

MedicineNet Daily News

Trump Postpones Move to Dismantle Obamacare 2019-04-04 03:00:00Title: Trump Postpones Move to Dismantle ObamacareCategory: Health NewsCreated: 4/2/2019 12:00:00 AMLast Editorial Review: 4/3/2019 12:00:00 AM

Brain Scans Spot, Track Alzheimer's 2019-04-04 03:00:00Title: Brain Scans Spot, Track Alzheimer'sCategory: Health NewsCreated: 4/2/2019 12:00:00 AMLast Editorial Review: 4/3/2019 12:00:00 AM

Severe 'Mono' Infection May Raise Risk for Chronic 2019-04-04 03:00:00Title: Severe 'Mono' Infection May Raise Risk for Chronic Fatigue SyndromeCategory: Health NewsCreated: 4/2/2019 12:00:00 AMLast Editorial Review: 4

AHA News: Couple Kept the Faith as Baby 2019-04-04 03:00:00Title: AHA News: Couple Kept the Faith as Baby Neared Death -- and Then a Transplant Saved HimCategory: Health NewsCreated: 4/2/2019 12:00:00 AMLast E

Easy Ways to Reap the Benefits of Extra 2019-04-04 03:00:00Title: Easy Ways to Reap the Benefits of Extra Virgin Olive OilCategory: Health NewsCreated: 4/3/2019 12:00:00 AMLast Editorial Review: 4/3/2019 12:00

Mick Jagger to Have Heart Valve Surgery 2019-04-04 03:00:00Title: Mick Jagger to Have Heart Valve SurgeryCategory: Health NewsCreated: 4/2/2019 12:00:00 AMLast Editorial Review: 4/3/2019 12:00:00 AM

Treatment Advances Making Pancreatic Cancer a Less Deadly 2019-04-04 03:00:00Title: Treatment Advances Making Pancreatic Cancer a Less Deadly DiseaseCategory: Health NewsCreated: 4/2/2019 12:00:00 AMLast Editorial Review: 4/3/2

Health Tip: Taming Allergies 2019-04-04 03:00:00Title: Health Tip: Taming AllergiesCategory: Health NewsCreated: 4/3/2019 12:00:00 AMLast Editorial Review: 4/3/2019 12:00:00 AM

Teaching Kids the Importance of an Apology 2019-04-04 03:00:00Title: Teaching Kids the Importance of an ApologyCategory: Health NewsCreated: 4/3/2019 12:00:00 AMLast Editorial Review: 4/3/2019 12:00:00 AM

Health Tip: Celebrate Graduation Responsibly 2019-04-04 03:00:00Title: Health Tip: Celebrate Graduation ResponsiblyCategory: Health NewsCreated: 4/3/2019 12:00:00 AMLast Editorial Review: 4/3/2019 12:00:00 AM

Paralyzing Illness Could Become More Common in the 2019-04-04 03:00:00Title: Paralyzing Illness Could Become More Common in the U.S.Category: Health NewsCreated: 4/3/2019 12:00:00 AMLast Editorial Review: 4/3/2019 12:00:

Americans' Pets Help Ease the Aging Process, Poll 2019-04-04 03:00:00Title: Americans' Pets Help Ease the Aging Process, Poll FindsCategory: Health NewsCreated: 4/3/2019 12:00:00 AMLast Editorial Review: 4/3/2019 12:00

Santé

Gynécologie au CUSM: une décision sur l'injonction attendue 2019-04-02 07:16:00La Cour supérieure du Québec devrait annoncer mardi après-midi si elle accorde une injonction temporaire aux professionnels de la

Chimiothérapie: des tests génétiques accessibles partout au Québec 2019-04-01 05:00:00Bonne nouvelle pour les gens atteints de cancer : trois analyses génétiques capables de déterminer si leur corps t

Contrôle des armes à feu: des médecins montent 2019-04-01 05:00:00Mercredi, un regroupement de médecins de partout au Canada favorable à un contrôle plus strict des armes à feu or

Démence chez les aînés: une équipe d'élite pour 2019-03-31 05:00:00Au son d'une valse, Gertrude Holzmann, 77 ans, exécute quelques pas de danse aux bras du préposé aux bénéfici

Quitter Facebook rendrait plus heureux 2019-03-31 00:00:00Comment vous sentiriez-vous si vous quittiez Facebook pendant un mois ? Une nouvelle étude réalisée par des chercheurs de l'Univ

Des chercheurs montréalais s'affairent à éradiquer la tuberculose 2019-03-29 12:29:00Alors que la tuberculose continue ses ravages en 2019, même au Québec, une commission internationale est formelle : il est possible

Infection à méningocoque: les funérailles de Julia Cianci 2019-03-29 06:23:00Les funérailles de la jeune femme qui a été emportée le 23 mars dernier à Montréal par une infection &a

Un outil pour mieux traiter les sportifs atteints 2019-03-29 05:00:00Une nouvelle étude coordonnée par la cardiologue montréalaise Julia Cadrin-Tourigny permettra de mieux traiter les pati

Remplacements articulaires: le Québec en tête pour les 2019-03-28 07:02:00Si vous avez besoin d'un nouveau genou ou d'une nouvelle hanche, c'est au Québec que vous avez la meilleure chance d'être opér

Toxoplasmose: six chasseurs intoxiqués par de la viande 2019-03-27 16:00:00Un groupe de six chasseurs québécois a été victime d'une forte intoxication, en décembre dernier, après avo

Près de 500 patients ont reçu un don 2019-03-27 09:24:00Transplant Québec rapporte mercredi que l'an dernier, 497 personnes ont bénéficié d'une transplantation d'organe au Qu&

Radio-Canada | Santé

Le secret de l’eau potable primée de la 2019-04-02 06:37:00Alors que certaines communautés autochtones éloignées sont aux prises avec de l'eau impropre à la consommation et des inf

Un médicament contre le VIH plus accessible à 2019-04-02 06:04:00Depuis quelques semaines, les personnes à risque de contracter le virus de l'immunodéficience humaine (VIH) dans la région de Qu

Le cannabis médicinal de plus en plus populaire 2019-04-02 04:03:00Même si la marijuana est maintenant légale, de plus en plus de consommateurs se tournent vers le cannabis thérapeutique. Explicati

Réforme du système de santé : des organismes 2019-04-01 20:54:00Des organismes francophones en Ontario réclament des amendements au projet de loi 74 sur la réforme de la santé du gouvernement F

La réforme des soins de santé de Doug 2019-03-31 16:23:00Pendant l'unique journée accordée pour s'inscrire, Queen's Park a été inondé de plusieurs centaines de demandes

Prévention de l'obésité : Agropur, Lassonde et Saputo 2019-03-30 11:58:00Les plus grandes entreprises alimentaires du Québec seraient des cancres en matière de prévention de l'obésité et

Trop gros pour l'avion-ambulance 2019-03-28 16:20:00Le service d'avion-ambulance mandaté par le CISSS de la Côte-Nord a refusé de transporter un patient requérant des soins d

Les coûts humains et sociaux de l'usage excessif 2019-03-27 04:05:00En janvier dernier, le nouveau Guide alimentaire canadien a surpris en consacrant, pour la première fois de son histoire, une section sur les r

Global News : Health

Unvaccinated: How ‘vaccine hesitancy’ became a threat to 2019-04-02 06:00:32Toronto mother Sabrina Bacchus is one of a growing group of Canadian parents who are vaccine hesitant.

‘Fertility isn’t funny’: Why you shouldn’t pretend to 2019-04-01 15:15:26According to Statistics Canada, roughly 16 per cent of couples in Canada experience infertility — and it's a condition that can take a serious

Federal NDP rolls out Pharmacare Plan nearly 6 2019-04-01 14:07:40Federal NDP Leader Jagmeet Singh has introduced his pharmacare plan, a signature part of his party's upcoming election platform.

More U.S. measles cases so far this year 2019-04-01 12:59:42The number of measles cases in the first three months of 2019 have already surpassed all U.S. measles cases last year.

Mozambique records first cholera death in cyclone aftermath 2019-04-01 11:02:03Health authorities are racing to vaccinate people against cholera, after more than 500 cases and one death.

Canadian autism group calls on federal government for 2019-04-01 10:58:32To kick off autism month in Canada, the Canadian Autism Spectrum Disorders Alliance (CASDA) released a blueprint for a national strategy for autism sp

China blames U.S. for fentanyl abuse, expands controlled 2019-04-01 10:26:07U.S. culture caused the continuing opioid crisis, not illegal exports of fentanyl from China, a Chinese official said.

Unvaccinated: Pockets of Canada vulnerable to serious outbreaks 2019-04-01 08:12:03Health officials have identified a number of other places across Canada that are vulnerable to outbreaks because they are largely unprotected. 

Herpes in space: How research on astronauts’ ailments 2019-03-31 06:00:46Space travel has a negative effect on the human body, including reactivating dormant viruses like herpes.

Cholera cases nearly double in 1 day in 2019-03-30 23:15:13The cholera cases have been discovered in the port city of Beira, whose half-million residents and especially those in crowded, poor neighbourhoods ar

TORONTO STAR | LIFE |

Do you have allergies? They could be all 2019-04-01 17:49:01Doctors have long suspected a connection between allergies and the psyche, and while emotions and psychological stress do not cause allergies, they ca

How active recovery can help you rebound from 2019-03-31 08:00:00Low-intensity workouts like yoga, self-massage and hiking can help reduce muscle soreness and improve performance.

What’s the deal with all the black food 2019-03-24 06:00:00Activated charcoal, fulvic and humic acid make food more Instagrammable and come with lofty health claims, but is it all just (black) smoke and mirror

Introduce peanut products to children as early as 2019-03-22 16:40:58Introducing allergenic foods to infants before they turn 1 can help the baby’s body develop a tolerance to them, according to a report from the

Markham Stouffville Hospital world leader for system of 2019-03-21 16:24:49In May, Markham Stouffville Hospital will launch a new electronic system to help prevent pediatric patients from getting sicker.

Can intermittent fasting help with weight loss? 2019-03-17 06:00:00Eating until you are satisfied and less often is key to maintaining a healthy weight, Toronto doctor says.

Spinning has taken over Toronto. These are the 2019-03-15 12:21:49Have you joined the spinning revolution yet? Start with these eight studios

It’s World Sleep Day. Here’s 5 tips for 2019-03-15 05:00:00Ever lie awake at night calculating the hours til you have to get up? These tips will help you combat that sleep anxiety for more meaningful rest.

Dog walking risks higher among seniors 2019-03-11 23:49:49University of Pennsylvania researchers show number of dog-walking fractures in people aged 65 and older more than doubled between 2004 and 2017.

New concern on college campuses: ‘drunkorexia,’ a combination 2019-03-11 09:00:00Campus authorities and researchers are reporting a practice that turns the full-stomach drinking strategy on its head: Rather than filling up before a

Low-carb diets linked to heart disorder, study says 2019-03-11 00:00:00Scientists discover people who have a higher daily low-carb intake are 18 per cent more likely to develop AFib, the most common heart rhythm disorder.

What’s a vaginal steam and do you need 2019-03-10 09:00:00Pap Spas and pampered paps are a real thing, but are they really necessary?

Santé

Un décès sur cinq lié à une mauvaise 2019-04-03 18:58:56Selon une étude, les principales carences dans l’alimentation mondiale concernent les noix et les graines, le lait et les cér&eacu

Des médecins réclament un contrôle plus strict des 2019-04-03 18:16:08Des médecins plaidant pour un contrôle plus strict des armes à feu ont manifesté dans une dizaine de villes canadiennes, me

Aide médicale à mourir: le tiers des demandes 2019-04-03 17:23:05Depuis la mise en place de l’aide médicale à mourir au Québec, 34 % des demandes n’ont pas été men&eacu

Un Québécois payé pour fumer du cannabis 2019-04-03 16:00:00José Dominguez est le seul Québécois parmi huit personnes choisies qui recevront jusqu’à 1000 $ par mois pour tester

Comment empêcher la peau de vieillir? Des chercheurs 2019-04-03 13:54:07Une protéine pourrait jouer un rôle clé contre le vieillissement de la peau, selon un mécanisme décrit mercredi par

Près de 200 enfants intoxiqués à l’acétaminophène en 2019-04-03 13:18:43Près de 200 jeunes enfants au Québec ont été victimes d’une intoxication à l’acétaminophè

La pollution de l’air ampute l’espérance de vie 2019-04-03 06:15:55La pollution de l’air va amputer l’espérance de vie des enfants nés aujourd’hui dans le monde de 20 mois en moyenne.

Rappel de fromage Mizythra en raison de la 2019-04-03 05:23:50L’entreprise Distribution MFG Inc. procède au rappel de fromage «Mizythra sec de Crète» de la marque Oreinos Mylopotam

3 médecins déboutés en cour 2019-04-02 20:33:40Trois médecins qui voulaient empêcher la fermeture de la clinique gynécologique de l’Hôpital de Lachine à Montr

Rendez-vous santé Québec: Barrette accuse son parti d’avoir 2019-04-02 18:58:37Gaétan Barrette accuse l’ancien bras droit de Philippe Couillard de l’avoir empêché de régler l’acc&egrav

Réseau de la santé : une journée sans 2019-04-02 17:58:44Les professionnelles en soins du réseau de la santé ne feront pas de temps supplémentaire obligatoire lundi prochain.

Stabilisation mondiale du nombre de cancers de la 2019-04-02 13:04:48Le cancer de la prostate est le cancer masculin le plus fréquent dans 96 pays, mais le nombre et la mortalité se sont stabilisés


Disclaimer and Notice:WorldProNews.com is not responsible of these news or any information published on this website.